Steffen Pietzke Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Steffen Pietzke.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Steffen Pietzke. Steffen Pietzke is a Controller and CAO in PDL BIOPHARMA, INC. ($PDLI) and a VP, Finance and CAO in PDL BIOPHARMA, INC. ($PDLI) and a VP Fin & Chief Acct Officer in Tricida, Inc. ($TCDA) and a VP Fin & Chief Acct Officer in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Address: 932 SOUTHWOOD BLVD. INCLINE VILLAGE 89451 NV
Companies in which Steffen Pietzke is an Insider
ALX ONCOLOGY HOLDINGS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steffen Pietzke: VP Fin & Chief Acct Officer
Holdings: 3,000 shares
Latest Transaction: Jul 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Steffen Pietzke: VP, Finance and CAO, Controller and CAO
Holdings: 139,587 shares
Current Value: $308,487
Latest Transaction: Dec 19 2017
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tricida, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Steffen Pietzke: VP Fin & Chief Acct Officer
Holdings: 10,527 shares
Latest Transaction: Feb 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Steffen Pietzke
Sentiment: All, ALXO, PDLI, TCDA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 19.00 | 41,789 | 793,991 | 41,789 | |
| Feb 26 2020 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 35.12 | 60,000 | 2,107,200 | 60,000 | |
| Aug 23 2019 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Option Exercise | A | 34.27 | 10,000 | 342,700 | 10,000 | |
| Jul 02 2018 | TCDA | Tricida, Inc. | Pietzke Steffen | VP Fin & Chief Acct ... | Buy | P | 19.00 | 10,527 | 200,013 | 10,527 | 0 to 10.5 K |
| Dec 19 2017 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | VP, Finance and CAO | Sell | D | 0.00 | 5,513 | 0 | 139,587 | 145.1 K to 139.6 K (-3.80 %) |
| Mar 07 2017 | PDLI | PDL BIOPHARMA, INC ... | Pietzke Steffen | Controller and CAO | Grant | A | 2.04 | 98,039 | 200,000 | 145,100 | 47.1 K to 145.1 K (+208.32 %) |